PYRIMIDINE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y RECEPTOR LIGANDS
申请人:F. Hoffman-la Roche AG
公开号:EP1335906A1
公开(公告)日:2003-08-20
US6657060B2
申请人:——
公开号:US6657060B2
公开(公告)日:2003-12-02
[EN] PYRIMIDINE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y RECEPTOR LIGANDS<br/>[FR] DERIVES DE PYRIMIDINE ET LEUR UTILISATION EN TANT QUE LIGANDS DE RECEPTEUR DU NEUROPEPTIDE Y
申请人:HOFFMANN LA ROCHE
公开号:WO2002038551A1
公开(公告)日:2002-05-16
Compounds of Formula (I), as well as pharmaceutically usable salts and esters thereof, wherein R?1, R2, R3, R4, A?1 and A2¿ have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, diabetes, eating disorders and obesity.
Pyrimidine derivatives
申请人:——
公开号:US20020086858A1
公开(公告)日:2002-07-04
Pyrimidine derivatives have been found to be useful as neuropeptide Y receptor ligands and particularly as antagonists. These pyrimidine derivatives may be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, diabetes, eating disorders, and obesity.